Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma

Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myelomaBendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma, Published online: 31 July 2018; doi:10.1038/s41408-018-0104-5Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma

Source: Blood Cancer Journal - July 31, 2018 Category: Hematology Authors: Dharshan Sivaraj Michael M Green Yubin Kang Gwynn D Long David A Rizzieri Zhiguo Li Anderson H Garrett Jackie L McIntyre Nelson J Chao Cristina Gasparetto Source Type: research